首页 >>2020年03期
幽门螺杆菌感染与心血管疾病及其危险因素关系研究进展
作者:唐碧玮 王学梅 吴静

摘要:

近年来,幽门螺杆菌的高感染率及其对心血管疾病的影响引发了人们的关注,其可能通过炎症反应、免疫反应和损伤内皮细胞等多种机制直接参与冠心病、脑卒中等心血管疾病的发生发展,同时也可在动脉粥样硬化、高血压、高同型半胱氨酸血症和血脂异常等心血管疾病危险因素的形成中发挥重要作用。但目前国内外研究结果尚不一致,仍需要通过大量实验进一步确证,以采取有效措施控制心血管疾病的发生率。本文现就幽门螺杆菌与心血管疾病的流行情况、国内外研究现状及其相互作用机制进行综述。

关键词:螺杆菌,幽门;心血管疾病;动脉粥样硬化

Abstract:

In recent years, the high infection rate of Helicobacter pylori and its impact on cardiovascular disease have attracted public attention. It may directly affect coronary heart disease, stroke, etc. through various mechanisms such as inflammation, immune response, and damage to endothelial cells. It could also play an important role in the formation of cardiovascular disease risk factors such as atherosclerosis, hypertension, hyperhomocysteinemia, and dyslipidemia. However, domestic and international research results are still inconsistent, and a large number of experiments are still required to confirm it to take effective measures to control the incidence of cardiovascular disease. This article reviews the prevalence of Helicobacter pylori and cardiovascular disease, the interaction mechanisms and the status of relevant domestic and international researches.

Key words: Helicobacter pylori;Cardiovascular diseases;Atherosclerosis

发表日期:2020/3

引用本文:

图/表:

    暂无图表

参考文献:

[1]WarrenJR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis[J]. Lancet,1983,1 (8336):1273-1275. DOI: 10.1016/S0140-6736(83)92719-8.
[2]MarshallBJ, WarrenJR. Unidentified curved bacilli in the stom-ach of patients with gastritis and peptic ulceration[J]. Lancet, 1984, 1 (8390):1311-1315. DOI: 10.1016/s0140-6736(84)91816-6.
[3]GravinaAG, ZagariRm, De MusisC, et al. Helicobacter pylori and extragastric diseases: A review[J]. World J Gastroenterol, 2018, 24(29): 3204-3221. DOI: 10.3748/wjg.v24.i29.3204.
[4]World Health Organization. Cardiovascular diseases (CVDs) [EB/OL]. (2017-05-17)[2019-10-17] https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
[5]RosenfeldME, CapbellLA. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis[J]. Thromb Haemost, 2011,106(5): 858-867. DOI: 10.1160/TH11-06-0392.
[6]NagyP, JohanssonS, Molloy-BlandM. Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA[J].Gut Pathog, 2016,8:8. DOI: 10.1186/s13099-016-0091-7.
[7]JiangJ, ChenY, ShiJ, et al. Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China[J]. Eur J Clin Microbiol Infect Dis, 2017, 36(2): 199-212.
[8]RoghaM, NikvarzM, PourmoghaddasZ,et al. Is helicobacter pylori infection a risk factor for coronary heart disease? [J]. ARYA Atheroscler, 2012, 8(1):5-8.
[9]GoAS, MozaffarianD, RogerVL, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association[J]. Circulation, 2014, 129(3): e28-e292.DOI: 10.1161/01.cir.0000441139.02102.80.
[10]WilleitP, FreitagDF, LaukkanenJA, et al. Asymetric dimethylarginine and cardiovascular risk: systematic review and Meta-analysis of 22 prospective studies[J]. J Am Heart Assoc, 2015, 4(6):e001833. DOI: 10.1161/JAHA.115.001833.
[11]AydemirS, ErenH, TekinIO, et al. Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels[J]. Mediators Inflamm,2010:685903. DOI: 10.1155/2010/685903.
[12]PatelP, MendallMA, CarringtonD, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors[J]. BMJ, 1995, 311(7007):7111-714. DOI: 10.1136/bmj.311.7007.711.
[13]FarsakB, YildirirA, Aky?nY, et al. Detection of Chiamydia Pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR[J]. J Clin Microbiol, 2000, 38(12): 4408-4411.
[14]AmerisoSF, FridmanEA, LeiguardaRC, et al. Detection of Helicobacter pylori in human carotid atherosclerotic plaques[J]. Stroke, 2001,32(2):385-391. DOI: 10.1161/01.str.32.2.385.
[15]ChengTJ, GuoHR, ChangCY, et al. The association between peptic ulcer disease and ischemic stroke: a population-based longitudinal study[J]. Medicine (Baltimore), 2016,95(22): e3797. DOI: 10.1097/MD.0000000000003797.
[16]LiC, Enstr?mG, HedbladB, et al. Risk factors for stroke in subjects with normal blood pressure: a prospective cohort study[J]. Stroke, 2005, 36(2):234-238. DOI: 10.1161/01.STR.0000152328.66493.0a.
[17]刘静,刘浠,周石.缺血性脑卒中亚型与幽门螺杆菌感染相关性研究[J].中国病原生物学杂志,2017,12(4):366-369. DOI: 10.13350/j.cjpb.170418.
[18]Shindler-ItskovitchT, ChodickG, ShaleV, et al. Heliobacter pylori infection and prevalence of stroke[J]. Helicobacter, 2019, 24(1): e12553. DOI: 10.1111/hel.12553.
[19]YuM, ZhangY, YangZ, et al. Association between Helicobacter pylori infection and stroke: a meta-analysis of prospective observational studies[J]. J Stroke Cerebrovasc Dis, 2014, 23(9):2233-2239. DOI: 10.1016/j.jstrokecerebrovasdis.2014.04.020.
[20]IkedaA, IsoH, SasazukiS, et al. The combination of Helicobacter pylori-and cytotoxin-associated gene-A seropositivity in relation to the risk of myocardial infarction in middle-aged Japanese: The Japan Public Health Center-Based study[J]. Atherosclerosis, 2013, 230(1):67-72. DOI: 10.1016/j.atherosclerosis.2013.06.013.
[21]YangX, GaoY, ZhaoX, et al. Chronic Helicobacter pylori infection and ischemic stroke subtypes[J]. Neurol Res, 2011, 33(5):467-472. DOI: 10.1179/016164111X13007856083963.
[22]Frosteg?rdJ. Immunity, atherosclerosis and cardiovascular disease[J]. BMC Med2013,11:117. DOI:10.1186/1741-7015-11-117.
[23]MaseriA. Inflammation, atherosclerosis, and ischemic events-exploring the hidden side of the moon[J]. N Engl J Med, 1997, 336(14):1014-1016. DOI: 10.1056/NEJM199704033361409.
[24]IshidaY, SuzukiK, TakiK, et al. Significant association between Helicobacter pylori infection and serum C-reactive protein[J]. Int J Med Sci, 2008, 5(4):224-229. DOI: 10.7150/ijms.5.224.
[25]AndreollaHF, BonaLR, SanderGB, et al. Lack of association between Helicobacter pylori′s virulence and increased serum c-reactive protein levels in functional dyspeptic patients[J]. Arq Gastroenterol, 2016, 53(1):49-54. DOI: 10.1590/S0004-28032016000100010.
[26]RussoF, JirilloE, ClementeC, et al. Circulating cytokines and gastrin levels in asumptomatic subjects infected by Helicobacter pylori (H. pylori) [J]. Immunopharmacol Immunotoxicol, 2001,23(1):13-24. DOI: 10.1081/IPH-100102563.
[27]ConsolazioA, BorgiaMC, FerroF, et al. Increased thrombin generation and circulating levels of tumour necrosis factoralpha in patients with chronic Helicobacter pylori-positive gastritis[J]. Aliment Pharmacol Ther, 2004, 20(3):289-294. DOI: 10.1111/j.1365-2036.2004.02074.x.
[28]MaciorkowskaE, KaczmarskiM, PanasiukA, et al. Soluble adhesion molecules ICAM-1, VCAM-1, P-selectin in children with Hlicobacter pylori infection[J]. World J Gastroenterol, 2005, 11(43):6745-6750. DOI: 10.3748/wjg.v11.i43.6745.
[29]XuY, WangQ, LiuY, et al. Is Helicobacter pylori infection a critical risk factor for vascular dementia? [J]. Int J Neurosci, 2016, 126(10):899-903. DOI: 10.3109/00207454.2015.1081387.
[30]SlomianyBL, SlomianyA. Involvement of p38 MAPK-dependent activator protein (AP-1) activation in modulation of g astric mucosal inflammatory responses to Helicobacter pylori by ghrelin[J]. Inflammopharmacology, 2013, 21(1):67-78. DOI: 10.1007/s10787-012-0141-9.
[31]SlomianyBL, SlomianyA. Induction in gastric mucosal prostaglandin and nitric oxide by Helicobacter pylori is dependent on MAPK/ERK-mediated activation of IKK-β and cPLA2: modulatory effect of ghrelin[J]. Inflammopharmacology, 2013, 21(3):241-251. DOI: 10.1007/s10787-013-0169-5.
[32]SlomianyBL, SlomianyA. Modulation of gastric mucosal inflammatory responses to Helicobacter pylori by ghrelin: Role of cNOS-dependent IKK-β S-nitrosylation in the regulation of COX-2 activation[J]. Am J Mol Biol, 2012, 2(2):113-123. DOI: 10.4236/ajmb.2012.22013.
[33]NasratSA, NasratAM. An alternative approach for the rising challenge of hypertensive illness via Helicobacter pylori eradication[J]. Cardiol Res, 2015, 6(1):221-225. DOI: 10.14740/cr382e.
[34]VahdatK, PourbehiMR, OstovarA, et al. Association of pathogen burden and hypertension: the Persian Gulf Healthy Healthy Heart Study[J]. Am J Hypertens, 2013, 26(9):1140-1147. DOI: 10.1093/ajh/hpt083.
[35]WanZ, HuL, HuM, et al. Helicobacter pylori infection and prevalence of high blood pressure among Chinese adults[J]. J Hum Hypertens, 2018, 32(2):158-164. DOI: 10.1038/s41371-017-0028-8.
[36]LuC, JiaH, XuA, et al. Helicobacter pylori infection and pepsinogen levels have clinical significance in hypertension patients[J]. Int J Clin Exp Med, 2014, 7(12): 5675-5680.
[37]尹香君,李立明,项新华.同型半胱氨酸和心血管疾病的流行病学研究进展[J].中华预防医学杂志, 2002, 32(2): 123-125. DOI: 10.3760/j:issn:0253-9624.2002.02.016.
[38]Van OijenMG, SipponenP, LaheijRJ, et al. Gastric status and Vitamin B12 levels in cardiovascular patients[J]. Dig Dis Sci, 2007, 52(9):2186-2189. DOI: 10.1007/s10620-006-9260-8.
[39]Fernández-Ba?aresF, MonzónH, FornéM. A short review of malabsorption and anemia[J]. World J Gastroenterol, 2009, 15(37): 4644-4652. DOI: 10.3748/wjg.15.4644.
[40]RautSC, PatilVW, DaiviSM, et al. Helicobacter pylori gastritis, a presequeale to coronary plaque[J]. Clin Pract, 2015, 5(1):717. DOI: 10.4081/cp.2015.717.
[41]RasoolS, AbidS, IqbalMP, et al. Relationship between vitamin B12, folate and homocysteine levels and H.pylori infection in patients with functional Dyspepsia: a cross-section study[J]. BMC Res Notes, 2012,5:206. DOI: 10.1186/1756-0500-5-206.
[42]JavadiL, Pourghassem GargariB, SalekzamaniS, et al. Folate and homocysteine levels and their association with dietary intakes in lranian patients infected with Helicobacter pylori: a case-control study[J]. Acta Med Iran, 2015, 53(3):162-167.
[43]Marti-CarvajalAJ, SolàI, LathyrisD, et al. Homocysteine-lowering interventions for preventing cardiovascular events[J]. Cochrane Database Syst Rev, 2017, 8: CD006612. DOI: 10.1002/14651858.CD006612.pub5.
[44]杨学礼,顾东风.高筑控制高胆固醇血症与心血管疾病的"防洪大堤" [J].中华预防医学杂志,2017,51(1): 1-4. DOI:10.3760/cma.j.issn.0253-9624.2017.01.001.
[45]Niemel?S, KarttunenT, KorhonenT, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? [J]. Heart, 1996, 75(6): 573-575. DOI: 10.1136/hrt.75.6.573.
[46]KimTJ, LeeH, KangM, et al. Heliicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease[J]. Sci Rep, 2016,6:38015. DOI: 10.1038/srep38015.
[47]SunY, FuD, WangYK, et al. Prevalence of Helicobacter pylori infection and its association with profiles[J]. Bratisl Lek Listy, 2016, 117(9):521-524. DOI: 10.4149/bll_2016_103.
[48]JamkhandePG, GattaniSG, FarhatSA. Helicobacter pylori and cardiovascular complications: a mechanism based review on role of Helicobacter pylori in cardiovascular diseases[J]. Integer Med Res, 2016, 5(4):244-249. DOI: 10.1016/j.imr.2016.05.005.
[49]漆军华,石永强,张敦福,等.幽门螺杆菌与冠心病相关性及对氧化应激的影响[J].中西医结合心脑血管并杂志, 2017, 15(12):1533-1534. DOI:10.3969/j.issn.1672-1349.2017.12.037.
[50]朱华伟,任保仙,齐进兴,等.脑梗死与幽门螺杆菌感染相关性研究[J].中华医院感染学杂志,2015,25(16):3669-3671. DOI: 10.11816/cn.ni.2015-142105.
[51]SchwertherHA, JacksonWG, TolanG. Association of low serum concentration of bilirubin with increased risk of coronary artery disease[J]. Clin Chem, 1994, 40(1):18-23.
[52]胡柳,万政策,吕永曼,等.幽门螺杆菌感染与血清胆红素的相关性研究[J].胃肠病学,2019, 24(1):30-34. DOI: 10.3969/j.issn.1008-7125.2019.01.007.

用户评论 0条

用户名: 密码: 登陆 注册
 
  • 9
  • 3
  •  4 : 页次:0/0页 共0条记录 5条/每页
    关于我们 | 专家风采 | 会员注册 | 继续教育
    地 址:北京市西城区东河沿街69号正弘大厦511室 邮 编:100052
    电话:010-51322302
    版权所有 中华医学会及中华预防医学杂志编辑部
    京ICP备 07035254 号